has transitioned from a generic drug manufacturer to a global innovator after securing US FDA approval for Zaynich, India’s first indigenously discovered and developed novel antibiotic approved in the US. * Zaynich targets antimicrobial resistance (AMR) by treating difficult multidrug-resistant bacterial infections, addressing a critical global healthcare challenge. * The milestone strengthens India’s position in original drug discovery and could significantly increase the contribution of innovative products to Wockhardt’s future growth.

#StockInNews

615 likes·72 comments